Contrast developer Bracco Imaging has signed a marketing partnership with R.A.W., an Italian company that develops augmented reality technology for interventional oncology procedures.
R.A.W.'s Endosight guidance system is based on its Ablation-fit imaging software for 3D reconstruction, planning, and diagnosis, and it is designed for with CT-based percutaneous tumor ablation procedures.
Bracco will distribute Endosight and Ablation-fit through its European commercial network, it said.
